Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

361 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Disease susceptibility genes shared by primary biliary cirrhosis and Crohn's disease in the Japanese population.
Aiba Y, Yamazaki K, Nishida N, Kawashima M, Hitomi Y, Nakamura H, Komori A, Fuyuno Y, Takahashi A, Kawaguchi T, Takazoe M, Suzuki Y, Motoya S, Matsui T, Esaki M, Matsumoto T, Kubo M, Tokunaga K, Nakamura M. Aiba Y, et al. Among authors: komori a. J Hum Genet. 2015 Sep;60(9):525-31. doi: 10.1038/jhg.2015.59. Epub 2015 Jun 18. J Hum Genet. 2015. PMID: 26084578
Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis.
Nakamura M, Shimizu-Yoshida Y, Takii Y, Komori A, Yokoyama T, Ueki T, Daikoku M, Yano K, Matsumoto T, Migita K, Yatsuhashi H, Ito M, Masaki N, Adachi H, Watanabe Y, Nakamura Y, Saoshiro T, Sodeyama T, Koga M, Shimoda S, Ishibashi H. Nakamura M, et al. Among authors: komori a. J Hepatol. 2005 Mar;42(3):386-92. doi: 10.1016/j.jhep.2004.11.016. J Hepatol. 2005. PMID: 15710222
Enhanced expression of type I interferon and toll-like receptor-3 in primary biliary cirrhosis.
Takii Y, Nakamura M, Ito M, Yokoyama T, Komori A, Shimizu-Yoshida Y, Nakao R, Kusumoto K, Nagaoka S, Yano K, Abiru S, Ueki T, Matsumoto T, Daikoku M, Taniguchi K, Fujioka H, Migita K, Yatsuhashi H, Nakashima M, Harada M, Ishibashi H. Takii Y, et al. Among authors: komori a. Lab Invest. 2005 Jul;85(7):908-20. doi: 10.1038/labinvest.3700285. Lab Invest. 2005. PMID: 15856047 Free article.
Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis.
Nakamura M, Kondo H, Mori T, Komori A, Matsuyama M, Ito M, Takii Y, Koyabu M, Yokoyama T, Migita K, Daikoku M, Abiru S, Yatsuhashi H, Takezaki E, Masaki N, Sugi K, Honda K, Adachi H, Nishi H, Watanabe Y, Nakamura Y, Shimada M, Komatsu T, Saito A, Saoshiro T, Harada H, Sodeyama T, Hayashi S, Masumoto A, Sando T, Yamamoto T, Sakai H, Kobayashi M, Muro T, Koga M, Shums Z, Norman GL, Ishibashi H. Nakamura M, et al. Among authors: komori a. Hepatology. 2007 Jan;45(1):118-27. doi: 10.1002/hep.21472. Hepatology. 2007. PMID: 17187436
Elevated serum BAFF levels in patients with autoimmune hepatitis.
Migita K, Abiru S, Maeda Y, Nakamura M, Komori A, Ito M, Fujiwara S, Yano K, Yatsuhashi H, Eguchi K, Ishibashi H. Migita K, et al. Among authors: komori a. Hum Immunol. 2007 Jul;68(7):586-91. doi: 10.1016/j.humimm.2007.03.010. Epub 2007 Apr 17. Hum Immunol. 2007. PMID: 17584580
361 results